Like every person, every tumour is unique. Molecular information and genomic analysis play an increasingly important role in personalising medicine, especially for cancer patients.
Foundation Medicine is a molecular insights company that provides information to physicians and their patients through a deep understanding of the molecular changes that contribute to diseases such as cancer.
Foundation Medicine offers a full suite of comprehensive genomic profiling (CGP) assays to identify the molecular alterations in an individual patient's cancer and match them with relevant targeted therapies, immunotherapies and clinical trials.
In Aotearoa New Zealand, Roche’s Diagnostics division is the licensed distributor of FoundationOne®CDx and FoundationOne®Liquid CDx for patients with solid tumours, as well as FoundationOne®Heme for patients with sarcomas or haematological cancers including leukaemia, lymphoma and myeloma.
For more information please visit https://www.rochefoundationmedicine.com/#/en/international/home
General enquiries contact details:
IGENZ Ltd
Phone: 0064 9 307 3981
Email: [email protected]
Roche Diagnostics New Zealand Customer Service contact details:
Phone: 0800 652 634
Email: [email protected]
Roche Diagnostics New Zealand Ltd.
Level 1, No. 1 Sylvia Park
286 Mount Wellington Highway
Mount Wellington, Auckland 1060, New Zealand
Auckland, New Zealand
If your enquiry is related to Medical Information or reporting adverse events/product complaints, please use the following contact details:
Phone: 0800 363 622
Email: [email protected]